T-Net4h
Lexaria Updates its Ongoing Human Study GLP-1-H24-4
Lexaria Bioscience Corp., a global innovator in drug delivery platforms, provided progress updates on its Phase 1b, 12-week ...
T-Net4h
InMed's INM-901 Demonstrates Statistically Significant Reduction in Neuroinflammation in a Long-Term Preclinical Alzheimer's Disease Study
InMed Pharmaceuticals Inc., a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug ...
T-Net4h
Zymeworks Announces $50 Million Private Placement with EcoR1 Capital, Proceeds Expected to Extend Cash Runway Into H2 2027
Zymeworks Inc., a clinical-stage biopharmaceutical company developing novel, multifunctional biotherapeutics, announced that it has entered into a securities purchase agreement with funds affiliated ...
T-Net4h
Photonic Accelerates Timeline to 'Useful Quantum Computing' With Industry First Breakthrough Results in Error Correction
In an industry first, Photonic Inc. announced that it has introduced a new, low-overhead family of Quantum Low-Density Parity Check (QLDPC) codes that can efficiently perform both quantum computation ...